Advertisement
Screener

WAVE LIFE SCIENCES LTD. (WVE) Forms 3, 4 and 5: Stock Options

2.5 / 5 stars · 36/72 Roast Me

Add as a preferred source on Google

WAVE LIFE SCIENCES LTD. Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows in 2026. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2026-08-11: Reporting owner Wagner Heidi L; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2026-04-17: Reporting owner Wright Christopher I; Form 3; Security Share Option (Right to Buy); Transaction Holding.
  • 2026-04-17: Reporting owner Wright Christopher I; Form 3; Security Share Option (Right to Buy); Transaction Holding.
  • 2026-04-17: Reporting owner Ingelsson Erik; Form 3; Security Share Option (Right to Buy); Transaction Holding.

WVE insiders transactions against the stock price

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$3.20$4.72$6.97$10.28$15.17$22.382025-11-062026-11-06$1.17$2.11$3.81$6.87$12.40$22.382021-11-082026-11-06$1.17$2.55$5.57$12.16$26.55$57.962016-11-072026-11-06$1.17$2.55$5.57$12.16$26.55$57.962015-11-112026-11-06$1.17$2.55$5.57$12.16$26.55$57.962015-11-112026-11-062016-06-16: 5 award or grants at $18.79 close — GUERCIOLINI ROBERTO, Moran Kyle, BOLNO PAUL and 2 more2016-07-11: 1 award or grant at $21.69 close — Panzara Michael A.2016-07-28: 1 option exercise at $19.17 close — GUERCIOLINI ROBERTO2016-08-16: 1 award or grant at $20.89 close — Regnante Keith2016-08-19: 1 option exercise at $22.43 close — GUERCIOLINI ROBERTO2016-11-10: 7 award or grants at $36.42 close — TAKANASHI KEN, Kolchinsky Peter, HENRY CHRISTIAN O and 4 more2016-12-07: 2 option exercises at $34.30 close — GUERCIOLINI ROBERTO2017-01-25: 5 award or grants at $29.05 close — Vargeese Chandra, Regnante Keith, BOLNO PAUL and 2 more2017-02-01: 1 award or grant at $28.80 close — Rawcliffe Adrian2017-08-10: 6 award or grants at $18.10 close — Rawcliffe Adrian, Kolchinsky Peter, TAKANASHI KEN and 3 more2017-11-22: 1 option exercise at $35.45 close — Vargeese Chandra2018-01-23: 5 award or grants at $40.05 close — Vargeese Chandra, Francis Chris, Regnante Keith and 2 more2018-01-23: 1 option exercise at $40.05 close — Vargeese Chandra2018-02-15: 2 option exercises at $52.25 close — Vargeese Chandra, Panzara Michael A.2018-02-16: 1 option exercise at $54.70 close — Francis Chris2018-02-20: 2 option exercises at $52.10 close — Francis Chris2018-05-02: 1 option exercise at $44.70 close — BOLNO PAUL2018-05-25: 1 option exercise at $44.90 close — BOLNO PAUL2018-05-29: 1 option exercise at $44.90 close — BOLNO PAUL2018-05-30: 2 option exercises at $46.85 close — Francis Chris, BOLNO PAUL2018-06-01: 1 option exercise at $48.45 close — Francis Chris2018-07-09: 1 option exercise at $37.45 close — Francis Chris2018-08-13: 6 award or grants at $46.70 close — Kolchinsky Peter, HENRY CHRISTIAN O, Verdine Gregory L. and 3 more2018-09-24: 3 option exercises at $55.20 close — Francis Chris, Regnante Keith, Vargeese Chandra2018-09-25: 1 option exercise at $53.90 close — Francis Chris2019-03-15: 1 option exercise at $45.73 close — BOLNO PAUL2019-08-05: 1 award or grant at $19.48 close — Baldry Mark2019-08-15: 6 award or grants at $20.34 close — Verdine Gregory L., HENRY CHRISTIAN O, Rawcliffe Adrian and 3 more2019-09-04: 3 award or grants at $21.03 close — CORRIGAN MARK, Wagner Heidi L, Pott Amy2019-12-03: 1 option exercise at $34.10 close — Vargeese Chandra2020-03-03: 5 award or grants at $8.17 close — Vargeese Chandra, Gaiero David G, BOLNO PAUL and 2 more2020-07-02: 1 option exercise at $9.91 close — BOLNO PAUL2020-08-18: 9 award or grants at $9.13 close — CORRIGAN MARK, Kolchinsky Peter, Verdine Gregory L. and 6 more2020-08-25: 1 option exercise at $12.67 close — BOLNO PAUL2020-09-15: 1 option exercise at $16.36 close — BOLNO PAUL2021-02-01: 5 award or grants at $10.48 close — Francis Chris, BOLNO PAUL, Panzara Michael A. and 2 more2021-03-24: 1 option exercise at $7.66 close — Moran Kyle2021-08-16: 8 award or grants at $5.97 close — Wagner Heidi L, Verdine Gregory L., TAKANASHI KEN and 5 more2022-01-01: 5 award or grants at $3.14 close — Moran Kyle, Panzara Michael A., BOLNO PAUL and 2 more2022-07-25: 5 award or grants at $2.83 close — Moran Kyle, Francis Chris, BOLNO PAUL and 2 more2022-08-15: 8 award or grants at $3.50 close — Rawcliffe Adrian, HENRY CHRISTIAN O, RA CAPITAL MANAGEMENT, L.P. | Shah Rajeev M. | Kolchinsky Peter | RA Capital Healthcare Fund LP and 5 more2022-10-27: 1 award or grant at $4.37 close — Verdine Gregory L.2023-02-17: 4 award or grants at $4.75 close — Vargeese Chandra, BOLNO PAUL, Francis Chris and 1 more2023-08-07: 8 award or grants at $4.59 close — Tan Aik Na, RA Capital Healthcare Fund LP | Kolchinsky Peter | RA CAPITAL MANAGEMENT, L.P. | Shah Rajeev M., TAKANASHI KEN and 5 more2024-02-05: 4 award or grants at $3.87 close — Francis Chris, BOLNO PAUL, Moran Kyle and 1 more2024-07-22: 1 option exercise at $6.18 close — Vargeese Chandra2024-08-12: 8 award or grants at $5.37 close — RA CAPITAL MANAGEMENT, L.P. | RA Capital Healthcare Fund LP | Shah Rajeev M. | Kolchinsky Peter, Rawcliffe Adrian, Tan Aik Na and 5 more2024-10-11: 1 option exercise at $8.61 close — Moran Kyle2024-10-16: 3 option exercises at $14.90 close — Francis Chris2024-11-08: 1 option exercise at $16.44 close — Francis Chris2024-11-25: 1 option exercise at $14.89 close — BOLNO PAUL2025-01-23: 1 option exercise at $11.94 close — Vargeese Chandra2025-02-04: 4 award or grants at $11.74 close — Moran Kyle, BOLNO PAUL, Francis Chris and 1 more2025-03-04: 2 option exercises at $11.23 close — Vargeese Chandra2025-03-05: 1 option exercise at $10.57 close — Verdine Gregory L.2025-03-07: 3 option exercises at $9.40 close — BOLNO PAUL, Verdine Gregory L.2025-03-20: 1 option exercise at $9.67 close — HENRY CHRISTIAN O2025-08-11: 8 award or grants at $8.11 close — RA Capital Healthcare Fund LP | RA CAPITAL MANAGEMENT, L.P. | Shah Rajeev M. | Kolchinsky Peter, CORRIGAN MARK, Tan Aik Na and 5 more2025-08-15: 1 option exercise at $9.76 close — Tan Aik Na2025-12-08: 3 award or grants at $18.52 close — Moran Kyle2025-12-08: 14 option exercises at $18.52 close — Rawcliffe Adrian, Wagner Heidi L, HENRY CHRISTIAN O and 2 more2025-12-09: 2 award or grants at $21.31 close — Moran Kyle2026-01-02: 1 option exercise at $15.95 close — Francis Chris2026-02-05: 4 award or grants at $12.75 close — Moran Kyle, BOLNO PAUL, Francis Chris and 1 more2026-02-26: 2 option exercises at $15.36 close — Francis Chris2026-08-11: 1 option exercise at $5.05 close — Wagner Heidi L

Logarithmic scale. Both lines share the same starting value for the selected range.

Markers: each transaction type positioned at that session's split-adjusted close. Tooltips retain the reported transaction price when available.

Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2026-08-11Wagner Heidi L
Director		4Stock Option (right to buy)
Derivative · Direct		M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−7,000
0 owned after		$5.97
exercise price		$5.052026-08-13
2026-04-17
holding as of filing		Wright Christopher I
Officer (Chief Medical Officer)		3Share Option (Right to Buy)
Derivative · Direct		Holding$5.94
exercise price		2026-04-17
2026-04-17
holding as of filing		Wright Christopher I
Officer (Chief Medical Officer)		3Share Option (Right to Buy)
Derivative · Direct		Holding$12.75
exercise price		2026-04-17
2026-04-17
holding as of filing		Ingelsson Erik
Officer (Chief Scientific Officer)		3Share Option (Right to Buy)
Derivative · Direct		Holding$5.85
exercise price		2026-04-17
2026-04-17
holding as of filing		Ingelsson Erik
Officer (Chief Scientific Officer)		3Share Option (Right to Buy)
Derivative · Direct		Holding$11.74
exercise price		2026-04-17
2026-04-17
holding as of filing		Ingelsson Erik
Officer (Chief Scientific Officer)		3Share Option (Right to Buy)
Derivative · Direct		Holding$12.75
exercise price		2026-04-17
2026-02-26Francis Chris
Officer (See Remarks)		4Share Option (right to buy)
Derivative · Direct		M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−17,900
143,200 owned after		$3.87
exercise price		$15.362026-02-27
2026-02-26Francis Chris
Officer (See Remarks)		4Share Option (right to buy)
Derivative · Direct		M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−15,294
61,175 owned after		$4.75
exercise price		$15.362026-02-27
2026-02-05Moran Kyle
Officer (Chief Financial Officer)		4Share Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+273,750
273,750 owned after		$12.75
exercise price		$12.752026-02-11
2026-02-05BOLNO PAUL
Director, Officer (President and CEO)		4Share Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,000,000
1,000,000 owned after		$12.75
exercise price		$12.752026-02-11
2026-02-05Francis Chris
Officer (See Remarks)		4Share Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+232,500
232,500 owned after		$12.75
exercise price		$12.752026-02-11
2026-02-05Vargeese Chandra
Officer (See Remarks)		4Share Option (right to buy)
Derivative · Direct		A Grant, award or other acquisition pursuant to Rule 16b-3(d)+273,750
273,750 owned after		$12.75
exercise price		$12.752026-02-11
2026-01-02Francis Chris
Officer (See Remarks)		4Share Option (right to buy)
Derivative · Direct		M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−9,375
0 owned after		$3.14
exercise price		$15.952026-01-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
GERON CORP (GERN)United States$0.803B-12.14
Faeth Therapeutics, Inc. (FTH)United States$0.750B
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Advertisement